“…The invention of a new stem cell induction technology and the development of iMSC allow the use of such therapy as a new strategy for treatment. It is evident that conventional sources of mesenchymal stem cells have certain negative aspects, namely ageing ability and low expansion property ( 47 - 49 ).…”